Search

for
Search:

GlossaryDipeptidyl Peptidase-4 Inhibitors (DPP-IV inhibitors)

block the enzyme DPP-4 to help regulate blood sugar

Dipeptidyl Peptidase-4 Inhibitors, often abbreviated as DPP-4 inhibitors, are a class of oral medications used to manage type 2 diabetes. They work by blocking the enzyme DPP-4, which results in increased levels of incretin hormones. These hormones help to regulate blood sugar by increasing insulin release and decreasing glucagon levels, particularly after meals.

Related Terms

Learn

0 / 0 results

— no results

Research

5 / 164 results

research Cardiovascular Profile of Pharmacological Agents Used for the Management of Polycystic Ovary Syndrome

4 citations , January 2019 in “Therapeutic Advances in Endocrinology and Metabolism”

Medications for PCOS don't seem to raise heart disease risk.

research The Current Status of the Pharmaceutical Potential of Juniperus L. Metabolites

19 citations , July 2018 in “Medicines”

Juniperus plants contain compounds with potential for developing various medical treatments.

research Dermatological Drugs, Topical Agents, and Cosmetics

1 citations , January 2015 in “Side effects of drugs annual”

The document concludes that various dermatological treatments and drugs can cause skin reactions and side effects.

research Synthetic Approaches for Pharmacologically Active Decorated Six-Membered Diazines

January 2023 in “IntechOpen eBooks”

The document concludes that specific methods for making diazine-based drugs can lead to high yields and are important for creating effective treatments for various diseases.

research Repurposing of Linagliptin and Similar FDA Approved Drugs as Antidiabetic Agents

May 2021 in “Letters in Applied NanoBioScience”

Pranlukast and mirabegron may work as new diabetes drugs.

View more "dpp-iv inhibitors" in research →

Community Join

0 / 0 results

— no results